PD

Prajakta Dhiraj Mhatre

Active Director Director DIN 07388437
DIN 07388437 First appointment Mar 2016 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Prajakta Dhiraj Mhatre

Data last updated:

Prajakta Dhiraj Mhatre is a Director at Shravani Pharma Private Limited (since 2016). The company operates in Chemicals and Materials.

DIN 07388437
Primary Designation Director
Industry Chemicals and Materials
First Appointment 14 Mar 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shravani Pharma Private Limited U24233MH2016PTC274376
Director14 Mar 20162016Active

Board colleagues of Prajakta Dhiraj Mhatre

NameDINCompanyDesignation
Dhiraj Ashok Mhatre07388416Shravani Pharma Private LimitedManager

Directorship timeline

Open interactive timeline →
Shravani Pharma Private Limited
Premium access

Shareholding and investment profile for Prajakta Dhiraj Mhatre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prajakta Dhiraj Mhatre

Prajakta Dhiraj Mhatre currently holds 1 directorship: Shravani Pharma Private Limited (Director, since 14 Mar 2016).

Prajakta Dhiraj Mhatre was first appointed on 14 Mar 2016 as Director at Shravani Pharma Private Limited.

The current boards of Prajakta Dhiraj Mhatre's companies include Dhiraj Ashok Mhatre (Shravani Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available